404 related articles for article (PubMed ID: 21383690)
21. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
22. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
23. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
Fan X; Matsui W; Khaki L; Stearns D; Chun J; Li YM; Eberhart CG
Cancer Res; 2006 Aug; 66(15):7445-52. PubMed ID: 16885340
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
[TBL] [Abstract][Full Text] [Related]
25. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
[TBL] [Abstract][Full Text] [Related]
26. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.
Wan Y; Fei XF; Wang ZM; Jiang DY; Chen HC; Yang J; Shi L; Huang Q
Chin J Cancer; 2012 Apr; 31(4):207-14. PubMed ID: 22360855
[TBL] [Abstract][Full Text] [Related]
27. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.
Li Y; Li A; Glas M; Lal B; Ying M; Sang Y; Xia S; Trageser D; Guerrero-Cázares H; Eberhart CG; Quiñones-Hinojosa A; Scheffler B; Laterra J
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9951-6. PubMed ID: 21628563
[TBL] [Abstract][Full Text] [Related]
28. Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.
Dong Y; Han Q; Zou Y; Deng Z; Lu X; Wang X; Zhang W; Jin H; Su J; Jiang T; Ren H
Mol Cell Biochem; 2012 Nov; 370(1-2):89-102. PubMed ID: 22829019
[TBL] [Abstract][Full Text] [Related]
29. A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
Sherman JH; Redpath GT; Redick JA; Purow BW; Laws ER; Jane JA; Shaffrey ME; Hussaini IM
J Neurosci Methods; 2011 May; 198(1):99-102. PubMed ID: 21402102
[TBL] [Abstract][Full Text] [Related]
30. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.
McCord AM; Jamal M; Shankavaram UT; Lang FF; Camphausen K; Tofilon PJ
Mol Cancer Res; 2009 Apr; 7(4):489-97. PubMed ID: 19372578
[TBL] [Abstract][Full Text] [Related]
31. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
32. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
33. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid-dependent signaling pathways and lineage events in the developing mouse spinal cord.
Paschaki M; Lin SC; Wong RL; Finnell RH; Dollé P; Niederreither K
PLoS One; 2012; 7(3):e32447. PubMed ID: 22396766
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.
Ding D; Lim KS; Eberhart CG
Acta Neuropathol Commun; 2014 Mar; 2():31. PubMed ID: 24685274
[TBL] [Abstract][Full Text] [Related]
36. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
37. Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties.
Hong X; Chedid K; Kalkanis SN
Int J Oncol; 2012 Nov; 41(5):1693-700. PubMed ID: 22922964
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling enhances nestin expression in gliomas.
Shih AH; Holland EC
Neoplasia; 2006 Dec; 8(12):1072-82. PubMed ID: 17217625
[TBL] [Abstract][Full Text] [Related]
39. p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
Panicker SP; Raychaudhuri B; Sharma P; Tipps R; Mazumdar T; Mal AK; Palomo JM; Vogelbaum MA; Haque SJ
Oncotarget; 2010 Aug; 1(4):289-303. PubMed ID: 21304179
[TBL] [Abstract][Full Text] [Related]
40. Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.
Eimer S; Dugay F; Airiau K; Avril T; Quillien V; Belaud-Rotureau MA; Belloc F
Neuro Oncol; 2012 Dec; 14(12):1441-51. PubMed ID: 23104476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
